Global Market For Diabetes Therapeutics And Diagnostics To Reach Nearly $157 Billion In 2017

Top Quote BCC Research is a leading information resource producing high-quality market research reports, newsletters, and conferences. End Quote
  • (1888PressRelease) December 07, 2012 - Wellesley, Mass. - According to a new technical market research report, GLOBAL MARKETS FOR DIABETES THEREAPEUTICS AND DIAGNOSTICS (HLC029D) from BCC Research (www.bccresearch.com), the global market for diabetes therapeutics and diagnostics was valued at $110 billion in 2011 and should reach nearly $118.7 billion in 2012. Total market value is expected to reach nearly $157 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 5.7%
    The market for diabetes therapeutics and diagnostics can be broken down into three regions: America, Europe, and Asia.

    America is expected to have a value of nearly $43 billion in 2012 and $54 billion in 2017, a CAGR of 4.7%.
    As a segment, Europe should total $26.8 billion in 2012 and $35.4 billion in 2017, a CAGR of 5.7%
    Asia is expected to total $48.9 billion in 2012 and $67.3 billion in 2017, a CAGR of 6.6%

    The current diabetes market includes insulin and insulin-delivery devices, various classes of oral hypoglycemic agents, and different types of instruments and devices used for diagnosis and especially for monitoring the level of diabetic control.

    Insulin is a hormone of large molecular size that has traditionally been administered by subcutaneous injection; if taken orally in a conventional tablet or capsule, it is destroyed by gut enzymes. Other hypoglycemic drugs are usually capable of being taken orally but some have inherently short half-lives, necessitating frequent dosage.

    This report will help its readers:
    Forecast the market size for diabetes therapeutics and diagnostics in terms of dollar and unit sales
    Classify the market size for diabetes therapeutics and diagnostics by geographical regions in terms of dollar and unit sales
    Highlight the roles played by major stakeholders and players
    Provide an overview of the activities of influential companies
    Examine crucial, innovative breakthroughs by means of a detailed patent analysis.

    This report will be valuable to many industry participants, including the following:
    Diabetes therapeutics specialists
    Diabetes diagnostics manufacturers
    End users and distributors
    Academic and research institutions
    Financial institutions.

    ###
space
space
  • FB Icon Twitter Icon In-Icon
Contact Information